FOLLICULAR LYMPHOMA ( FL)
Clinical trials for FOLLICULAR LYMPHOMA ( FL) explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA ( FL) trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA ( FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer patients get chance to continue promising drug in Long-Term safety study
Disease control CompletedThis study allowed patients with various cancers who had benefited from the drug tazemetostat in earlier trials to continue receiving it. The main goal was to monitor the drug's long-term safety in these patients. It was open to people who had not seen their cancer worsen and cou…
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Early trial tests new combo for tough blood cancers
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of combining two drugs, acalabrutinib and pembrolizumab, for people with various blood cancers. It involved 161 participants with conditions like lymphoma and leukemia. The main goal was to see if the combination …
Matched conditions: FOLLICULAR LYMPHOMA ( FL)
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC